Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization. 2018

Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
Department of Biotechnology, Chemistry, and Pharmacy , University of Siena , I-53100 Siena , Italy.

Nowadays, the increasing of multidrug-resistant pathogenic bacteria represents a serious threat to public health, and the lack of new antibiotics is becoming a global emergency. Therefore, research in antibacterial fields is urgently needed to expand the currently available arsenal of drugs. We have recently reported an alkyl-guanidine derivative (2), characterized by a symmetrical dimeric structure, as a good candidate for further developments, with a high antibacterial activity against both Gram-positive and Gram-negative strains. In this study, starting from its chemical scaffold, we synthesized a small library of analogues. Moreover, biological and in vitro pharmacokinetic characterizations were conducted on some selected derivatives, revealing notable properties: broad-spectrum profile, activity against resistant clinical isolates, and appreciable aqueous solubility. Interestingly, 2 seems neither to select for resistant strains nor to macroscopically alter the membranes, but further studies are required to determine the mode of action.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D018938 Caco-2 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. Caco 2 Cells,Caco-2 Cell,Cell, Caco-2,Cells, Caco-2
D019791 Guanidine A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC. Guanidine Hydrochloride,Guanidinium,Guanidinium Chloride,Guanidine Monohydrate,Guanidine Monohydrobromide,Guanidine Monohydrochloride,Guanidine Monohydroiodine,Guanidine Nitrate,Guanidine Phosphate,Guanidine Sulfate,Guanidine Sulfate (1:1),Guanidine Sulfate (2:1),Guanidine Sulfite (1:1),Guanidium Chloride,Chloride, Guanidinium,Chloride, Guanidium,Hydrochloride, Guanidine,Monohydrate, Guanidine,Monohydrobromide, Guanidine,Monohydrochloride, Guanidine,Monohydroiodine, Guanidine,Nitrate, Guanidine,Phosphate, Guanidine,Sulfate, Guanidine

Related Publications

Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
June 2015, Journal of medicinal chemistry,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
December 2018, Macromolecular rapid communications,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
October 2005, Bioorganic & medicinal chemistry letters,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
April 2018, Journal of medicinal chemistry,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
February 2024, European journal of medicinal chemistry,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
March 2008, Bioorganic & medicinal chemistry letters,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
October 2014, Journal of the American Chemical Society,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
January 2024, RSC medicinal chemistry,
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
February 2019, Molecules (Basel, Switzerland),
Carolina Pasero, and Ilaria D'Agostino, and Filomena De Luca, and Claudio Zamperini, and Davide Deodato, and Giuseppina I Truglio, and Filomena Sannio, and Rosita Del Prete, and Teresa Ferraro, and Daniela Visaggio, and Arianna Mancini, and Mario B Guglielmi, and Paolo Visca, and Jean-Denis Docquier, and Maurizio Botta
May 2021, Journal of medicinal chemistry,
Copied contents to your clipboard!